• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自然杀伤细胞功能障碍与癌症及利用 NK 细胞潜力进行癌症免疫治疗的新策略。

Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy.

机构信息

Department of Pathogenobiology, The Key Laboratory of Zoonosis, Chinese, Ministry of Education, College of Basic Medicine, Jilin University, Changchun, PR China.

Department of Pathogenobiology, The Key Laboratory of Zoonosis, Chinese, Ministry of Education, College of Basic Medicine, Jilin University, Changchun, PR China; The Key Laboratory for Bionics Engineering, Ministry of Education, Jilin University, Changchun, PR China; Engineering Research Center for Medical Biomaterials of Jilin Province, Jilin University, Changchun, PR China; Key Laboratory for Health Biomedical Materials of Jilin Province, Jilin University, Changchun, PR China; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang, PR China.

出版信息

Mol Immunol. 2022 Apr;144:58-70. doi: 10.1016/j.molimm.2022.02.015. Epub 2022 Feb 21.

DOI:10.1016/j.molimm.2022.02.015
PMID:35203022
Abstract

The continuous, in-depth exploration of the occurrence and development of cancer has shown that immune cell dysfunction is closely associated with tumor progression and poor clinical prognosis. The inhibition of the effector functions of immune cells by numerous immunosuppressive factors in the tumor microenvironment (TME) promotes the progression and metastasis of malignant tumors. Natural killer (NK) cells are the main effector cells in the anti-tumor innate immune system. Dysfunctional NK cells, characterized as weakened proliferation capacity and reduced production of effector cytokines, have limited ability to kill malignant cells and inhibit tumor progression. The reversal of the dysfunctional state of NK cells and enhancement of their effector functions is a promising strategy that could improve the effectiveness of cancer immunotherapy. In order to fully use of the cytotoxic effects of NK cells and revitalize the anti-tumor potential of NK cells in tumor patients, it is necessary to learn more about the characteristics of NK cell dysfunction in TME. This will provide valuable information for the development of personalized strategies to restore anti-tumor immunity. Here, we reviewed the characteristics of dysfunctional NK cells in the TME and latest progress in research, and discussed promising immunotherapy strategies that could utilize NK cell potential for cancer immunotherapy.

摘要

不断深入探索癌症的发生和发展表明,免疫细胞功能障碍与肿瘤进展和不良临床预后密切相关。肿瘤微环境(TME)中大量免疫抑制因子抑制免疫细胞的效应功能,促进恶性肿瘤的进展和转移。自然杀伤(NK)细胞是抗肿瘤固有免疫系统的主要效应细胞。功能失调的 NK 细胞表现为增殖能力减弱和效应细胞因子产生减少,其杀伤恶性细胞和抑制肿瘤进展的能力有限。逆转 NK 细胞的功能失调状态并增强其效应功能是一种很有前途的策略,可以提高癌症免疫治疗的效果。为了充分利用 NK 细胞的细胞毒性作用并恢复肿瘤患者 NK 细胞的抗肿瘤潜能,有必要更多地了解 TME 中 NK 细胞功能障碍的特征。这将为开发个性化策略以恢复抗肿瘤免疫提供有价值的信息。在这里,我们综述了 TME 中功能失调的 NK 细胞的特征以及最新的研究进展,并讨论了有希望的免疫治疗策略,这些策略可以利用 NK 细胞的潜力进行癌症免疫治疗。

相似文献

1
Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy.自然杀伤细胞功能障碍与癌症及利用 NK 细胞潜力进行癌症免疫治疗的新策略。
Mol Immunol. 2022 Apr;144:58-70. doi: 10.1016/j.molimm.2022.02.015. Epub 2022 Feb 21.
2
Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors.靶向免疫检查点:如何利用自然杀伤细胞对抗实体瘤。
Cancer Commun (Lond). 2023 Feb;43(2):177-213. doi: 10.1002/cac2.12394. Epub 2022 Dec 30.
3
Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.靶向肿瘤微环境中自然杀伤细胞-髓系细胞轴的治疗方法。
Front Immunol. 2021 Apr 19;12:633685. doi: 10.3389/fimmu.2021.633685. eCollection 2021.
4
Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer.自然杀伤 T 细胞和自然杀伤细胞为基础的癌症免疫治疗策略。
Biomolecules. 2023 Feb 10;13(2):348. doi: 10.3390/biom13020348.
5
Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.细胞因子在肿瘤微环境中协调自然杀伤细胞与髓系细胞的相互作用:对基于自然杀伤细胞的癌症免疫治疗的意义。
Front Immunol. 2021 Jan 29;11:621225. doi: 10.3389/fimmu.2020.621225. eCollection 2020.
6
Targeting Natural Killer Cells for Tumor Immunotherapy.靶向自然杀伤细胞进行肿瘤免疫治疗。
Front Immunol. 2020 Feb 19;11:60. doi: 10.3389/fimmu.2020.00060. eCollection 2020.
7
Natural killer cell-based strategies for immunotherapy of cancer.基于自然杀伤细胞的癌症免疫治疗策略。
Adv Protein Chem Struct Biol. 2022;129:91-133. doi: 10.1016/bs.apcsb.2022.02.001. Epub 2022 Mar 4.
8
NK Cell Dysfunction and Checkpoint Immunotherapy.自然杀伤细胞功能障碍与检查点免疫治疗。
Front Immunol. 2019 Aug 21;10:1999. doi: 10.3389/fimmu.2019.01999. eCollection 2019.
9
NK Cell Metabolism and Tumor Microenvironment.自然杀伤细胞代谢与肿瘤微环境。
Front Immunol. 2019 Sep 24;10:2278. doi: 10.3389/fimmu.2019.02278. eCollection 2019.
10
Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer.重塑的肿瘤免疫微环境(TIME)通过自然杀伤细胞在乳腺癌中的重编程。
Life Sci. 2023 Oct 1;330:121997. doi: 10.1016/j.lfs.2023.121997. Epub 2023 Aug 2.

引用本文的文献

1
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer.靶向B7-H3的新型三特异性杀伤细胞衔接器增强自然杀伤细胞对头颈部癌的抗肿瘤活性。
J Immunother Cancer. 2025 Jul 23;13(7):e011370. doi: 10.1136/jitc-2024-011370.
2
A comprehensive dataset for understanding immune dynamics in colorectal cancer.一个用于理解结直肠癌免疫动力学的综合数据集。
Data Brief. 2025 Jun 22;61:111817. doi: 10.1016/j.dib.2025.111817. eCollection 2025 Aug.
3
Tumor-educated cells in tumor microenvironment: Key drivers of immunotherapy resistance.
肿瘤微环境中的肿瘤驯化细胞:免疫治疗耐药性的关键驱动因素
Chin J Cancer Res. 2025 Jun 30;37(3):446-465. doi: 10.21147/j.issn.1000-9604.2025.03.12.
4
Natural Killer Cell Immune Checkpoints and Their Therapeutic Targeting in Cancer Treatment.自然杀伤细胞免疫检查点及其在癌症治疗中的靶向治疗
Research (Wash D C). 2025 Jun 3;8:0723. doi: 10.34133/research.0723. eCollection 2025.
5
Cellular plasticity and non-small cell lung cancer: role of T and NK cell immune evasion and acquisition of resistance to immunotherapies.细胞可塑性与非小细胞肺癌:T细胞和NK细胞免疫逃逸及对免疫疗法耐药性获得的作用
Cancer Metastasis Rev. 2025 Jan 25;44(1):27. doi: 10.1007/s10555-025-10244-8.
6
The diversity of natural killer cell functional and phenotypic states in cancer.癌症中自然杀伤细胞功能和表型状态的多样性
Cancer Metastasis Rev. 2025 Jan 24;44(1):26. doi: 10.1007/s10555-025-10242-w.
7
Transcriptomics profiling of the non-small cell lung cancer microenvironment across disease stages reveals dual immune cell-type behaviors.非小细胞肺癌微环境在疾病各阶段的转录组特征分析揭示了双重免疫细胞类型行为。
Front Immunol. 2024 Oct 31;15:1394965. doi: 10.3389/fimmu.2024.1394965. eCollection 2024.
8
Identification of a PANoptosis-related prognostic model in triple-negative breast cancer, from risk assessment, immunotherapy, to personalized treatment.三阴性乳腺癌中PAN细胞焦亡相关预后模型的鉴定:从风险评估、免疫治疗到个性化治疗
Heliyon. 2024 Sep 30;10(19):e38732. doi: 10.1016/j.heliyon.2024.e38732. eCollection 2024 Oct 15.
9
Natural Killer cells at the frontline in the fight against cancer.自然杀伤细胞在抗击癌症的第一线。
Cell Death Dis. 2024 Aug 23;15(8):614. doi: 10.1038/s41419-024-06976-0.
10
Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells.阻断 TGF-β 信号通路是人类诱导多能干细胞来源的 NK 细胞有效杀伤肝癌细胞所必需的。
Cell Stem Cell. 2024 Sep 5;31(9):1327-1343.e5. doi: 10.1016/j.stem.2024.06.009. Epub 2024 Jul 9.